Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 10, 1997, Pages 2027-2037

  Liu, Ning Pu ^a   Roberts, Wendy L ^a   Hale, Laura P ^a   Levesque, Marc C ^a   Patel, Dhavalkumar D ^a   Lu, Chun Lin ^a   Jaffe, Glenn J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD44; Cell density; Culture; Retinal pigment epithelium; Retinoic acid

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; EXON; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; MOLECULAR CLONING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN POLYMORPHISM;

ANTIGENS, CD44; BLOTTING, WESTERN; CELL COUNT; CELL DIVISION; CELLS, CULTURED; DNA PRIMERS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; PIGMENT EPITHELIUM OF EYE; POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TRETINOIN;

EID: 0030885807     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol Today. 1989;10:423-428.
2. Picker LJ, Nakache M, Butcher EC. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecule on diverse cell types. J Cell Biol. 1989;109:927-937.
3. Salmi M, Gron-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S. Regulated expression of exon v6 containing isoforms of CD44 in man: Down-regulation during malignant transformation of tumors of squamocellular origin. J Cell Biol. 1993;122:431-442.
4. Goodfellow PN, Banting G, Wiles MV, et al. The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10-44-2 is on human chromosome 11. Eur J Immunol. 1982;12:659-663.
5. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993; 54:271-335.
6. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem. 1992;267:4732-4739.
7. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 1992;89:12160-12164.
8. Günthert U. CD44 - a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol. 1993;184: 47-63.
9. Underhill C. CD44: The hyaluronan receptor. J Cell Sci. 1992;103:293-298.
10. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol. 1995;128:673-685.
11. Lokeshwar VB, Bourguignon LYW. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem. 1991;266:17983-17989.
12. Kalomiris EL, Bourguignon LYW. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol. 1988;106:319-327.
13. Aruffo A, Stamenkovic E, Meinick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1303-1313.
14. Culty M, Miyake K, Kincade PW, et al. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol. 1990;111:2765-2774.
15. Miyake K, Underhill CB, Lesley J, Kincade PM. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med. 1990;172:69-75.
16. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol. 1993;122: 257-264.
17. Carter WG, Wayner EA. Characterization of the class III collagen receptor, a phosphorylated transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem. 1988;263:4193-4201.
18. Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol. 1992;116:817-825.
19. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms. Cancer Cells. 1991;3:347-350.
20. Haynes BF, Hale LP, Patton KL, Martin ME, McCallum RM. Measurement of an adhesion molecule as an indicator of inflammatory disease activity: Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum. 1991;34:1434-1443.
21. Noble PW, Lake FR, Henson PM, Riches DW. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest. 1993;91:2368-2377.
22. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991;65:13-24.
23. Heider KH, Dämmrich J, Skroch-Angel P, et al. Differential expression of CD44 splice variants in intestinal-and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res. 1993;53:4197-4203.
24. Heider KH, Hofmann M, Horst E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol. 1993;120:227-233.
25. Rudy W, Hofmann M, Schwartz-Albiez R, et al. Two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: Each one individually suffices to confer metastatic behavior. Cancer Res. 1993;53:1262-1268.
26. Seiter S, Arch R, Reber S, et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med. 1993;177:443-455.
27. Rall CJN, Rustgi AK. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res. 1995;55:1831-1835.
28. Dall P, Heider KH, Sinn HP, et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer. 1995;60:471-477.
29. Herrlich P, Pals S, Ponta H. CD44 in colon cancer (review). Eur J Cancer. 1995;31A:1110-1112.
30. Duguid IG, Boyd AW, Mandel TE. The expression of adhesion molecules in the human retina and choroid. Aust N Z J Ophthalmol. 1991;19:309-316.
31. Chaitin MH, Wortham HS, Brun-Zinkernagel AM. Immunocytochemical localization of CD44 in the mouse retina. Exp Eye Res. 1994;58:359-365.
32. Machemer R, Laqua H. Pigment epithelial proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:1-23.
33. Machemer R, von Horn D, Aaberg TM. Pigment epithelial proliferation in human retinal detachment. Am J Ophthalmol. 1978;85:181-191.
34. Hilton G, Machemer R, Michels R, Okun E, Schepens C, Schwartz A. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121-125.
35. Alho AM, Underhill CB. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol. 1989;108:1557-1565.
36. Terpe A, Franke F, Stark H, et al. Occurrence of CD44 and its isoforms under orthological and pathological conditions. Verh Dtsch Ges Pathol. 1993;77:276-281.
37. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol. 1994;124:71-82.
38. Jaffe GJ, Van Le L, Valea F, et al. Expression of interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res. 1992;55:325-335.
39. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996; 62:155-169.
40. Kawasaki ES. Amplification of RNA. In: Innis MA, Gelfand DN, Sninsky JJ, White TJ, eds. PCR Protocols. London: Academic Press; 1990:21-27.
41. Jaffe GJ, Roberts WL, Wong HL, Yurochko AD, Cianciolo GJ. Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells. Exp Eye Res. 1995;60:533-543.
42. Hale LP, Haynes BF, McCachren SS. Expression of CD44 variants in human inflammatory synovitis. J Clin Immunol. 1995;15:300-311.
43. Telen MJ, Eisenbarth GS, Haynes BF. Human erythrocyte antigens: Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J Clin Invest. 1983;71:1878-1886.
44. Burnette WN. "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate - polyacrylamide gels to unmodified nitrocellulose and radiographie detection with antibody and radioiodinated protein A. Anal Biochem. 1981;112:195-203.
45. Patel DD, Hale LP, Whichard LP, Radcliff G, Mackay CR, Haynes BF. Expression of CD44 molecules and CD44 ligands during human thymic fetal development: Expression of CD44 isoforms is developmentally regulated. Int Immunol. 1995;7:277-286.
46. Nagai H, Kalnins VI. Normally occurring loss of single cells and repair of resulting defects in retinal pigment epithelium in situ. Exp Eye Res. 1996;62:55-61.
47. Koopmann G, Heider KH, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med. 1993;177:897-904.
48. Salles G, Zain M, Jiang WM, Boussiotis VA, Shipp MA. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: Characterization and comparison with normal activated B cells and epithelial malignancies. Blood. 1993;82:3539-3547.
49. Stauder R, Eisterer W, Thaler J, Günthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor. Blood. 1995;85:2885-2899.
50. Mirecka J, Marx D, Schauer A. Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer. Anticancer Res. 1995;15: 1459-1465.
51. Dali P, Heider KH, Hekele A, et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res. 1994;54:3337-3341.
52. Southgate J, Trejdosiewicz LK, Smith B, Seiby PJ. Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines. Int J Cancer. 1995;62:449-456.
53. Abbasi AM, Chester KA, Talbot IC, et al. CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer. 1993;29A: 1995-2002.
54. Oksala O, Salo T, Tammi R, et al. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem. 1995;43:125-135.
55. Brown TA, Bouchard T, St John T, Wayner E, Carter WG. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol. 1991;113:207-221.
56. Cooper DL, Dougherty G, Ham HJ, et al. The complex CD44 transcriptional unit: Alternative splicing of three internal exons generates the epithelial form of CD44. Biochem Biophys Res Commun. 1992;182:569-578.
57. Peehl DM, Wong ST, Stamey TA. Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells. Prostate. 1993;23:69-78.
58. Choi Y, Fuchs E. TGF-beta and retinoic acid: Regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regul. 1990;1:791-809.
59. Campochiaro PA, Hackett SF, Conway BP. Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1991;32:65-72.
60. Gross N, Beck D, Beretta C, Jackson D, Perruisseau G. CD44 expression and modulation on human neuroblastoma tumours and cell lines. Eur J Cancer. 1995; 31A:471-475.
61. Uhl-Steidl M, Muller-Holzner E, Zeimet AG, et al. Prognostic value of CD44 splice variant expression in ovarian cancer. Oncology. 1995;52:400-406.
62. Kirchhof B, Kirchhof E, Ryan SJ, Sorgente N. Vitreous modulation of migration and proliferation of retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci. 1989;30:1951-1957.
63. Berger AS, Jaffe GJ. Hyaluronic acid modulates cytokine expression by human RPE cells. Invest Ophthalmol Vis Sci. 1995;36:204. Abstract.